AQR Capital Management’s Sight Sciences SGHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$522K Buy
138,517
+40,847
+42% +$220K ﹤0.01% 3098
2025
Q4
$775K Sell
97,670
-2,483
-2% -$15.9K ﹤0.01% 2691
2025
Q3
$345K Buy
100,153
+4,727
+5% +$17.6K ﹤0.01% 3013
2025
Q2
$394K Buy
95,426
+42,097
+79% +$141K ﹤0.01% 2730
2025
Q1
$128K Buy
+53,329
New +$150K ﹤0.01% 2969
2024
Q1
Sell
-10,950
Closed -$56.5K 2497
2023
Q4
$56.5K Buy
+10,950
New +$33.8K ﹤0.01% 2307

Other funds holding SGHT

AQR Capital Management's SGHT Position: Q1 2026 in Review

AQR Capital Management increased its Sight Sciences (SGHT) stake by 42% in Q1 2026, buying an estimated $220K and bringing the position to 138,517 shares worth $522K. The position accounts for ﹤0.01% of the portfolio, ranked #3098.

AQR Capital Management first reported a position in SGHT in Q4 2023 and has held it in 6 quarters since. The position peaked at $775K in Q4 2025. 114 funds tracked by Wall St. Rank hold SGHT as of Q1 2026.

  • AQR Capital Management held 138,517 shares of Sight Sciences worth $522K as of Q1 2026.
  • AQR Capital Management bought 40,847 Sight Sciences shares in Q1 2026, an estimated $220K.
  • Sight Sciences made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #3098 holding.
  • AQR Capital Management first reported a position in Sight Sciences in Q4 2023 and has held it in 6 quarters since.
  • AQR Capital Management's Sight Sciences position peaked at $775K in Q4 2025.
  • 114 funds tracked by Wall St. Rank held Sight Sciences as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.